chalcone has been researched along with Leucocythaemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, Y; Li, M; Liu, D; Song, D; Tan, J; Wang, W; Yang, X; Zhao, L | 1 |
| Ascenso, OS; Estévez, F; González, I; Hernández, I; Leitão, EPT; Quintana, J; Rijo, P; Santos de Almeida, T | 1 |
| Abulkhair, HS; Fayed, EA; Husseiny, EM; Othman, EM | 1 |
| Brouard, I; Del Rosario, H; Estévez, F; García, C; González-Santana, D; Quintana, J; Saavedra, E; Spínola-Lasso, E; Tabraue, C | 1 |
| Brouard, I; Del Rosario, H; Estévez, F; Quintana, J; Saavedra, E | 1 |
| Chandgude, MG; Deshpande, MV; Gample, SP; Joshi, SP; Kulkarni, RR; Sarkar, D; Tupe, SG | 1 |
| Liu, H; Liu, Z; Teng, Y; Wang, H; Wang, L; Wu, M; Yu, P; Yuan, Y; Zhang, Q | 1 |
| Chiaradia, LD; Creczynski-Pasa, TB; de Cordova, CA; Nunes, RJ; Winter, E; Yunes, RA | 1 |
| Akihisa, T; Asami, S; Hasegawa, D; Kimura, Y; Motani, K; Nishimura, R; Suzuki, T; Tabata, K; Takayanagi, N; Ukiya, M | 1 |
| Chao, LR; Elomri, A; Magiatis, P; Seguin, E; Skaltsounis, AL; Tillequin, F | 1 |
| Hashimoto, Y; Kagechika, H; Kawachi, E; Shudo, K | 1 |
11 other study(ies) available for chalcone and Leucocythaemia
| Article | Year |
|---|---|
Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Chalcones; Chemistry, Pharmaceutical; Drug Design; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia; Mice; Models, Chemical | 2009 |
Design and synthesis of naphthylchalcones as novel anti-leukaemia agents.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Chalcone; Drug Design; Drug Screening Assays, Antitumor; Humans; Leukemia | 2021 |
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Drug Screening Assays, Antitumor; Humans; Leukemia; Molecular Docking Simulation; Molecular Structure; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship; Triazoles | 2022 |
Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells.
Topics: Amides; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Esters; HL-60 Cells; Humans; Leukemia; Leukocytes, Mononuclear; Structure-Activity Relationship | 2022 |
6'-Benzyloxy-4-bromo-2'-hydroxychalcone is cytotoxic against human leukaemia cells and induces caspase-8- and reactive oxygen species-dependent apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspase 8; Cathepsin D; Cell Line, Tumor; Cell Survival; Chalcone; Humans; Leukemia; Membrane Potential, Mitochondrial; Pepstatins; Reactive Oxygen Species | 2019 |
Antifungal dimeric chalcone derivative kamalachalcone E from Mallotus philippinensis.
Topics: Antifungal Agents; Aspergillus fumigatus; Chalcone; Chalcones; Cryptococcus neoformans; Drug Screening Assays, Antitumor; Euphorbiaceae; Fruit; Fungi; Humans; India; Inhibitory Concentration 50; Leukemia; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Extracts; Yeasts | 2014 |
3'-Geranyl-mono-substituted chalcone Xanthoangelovl induces apoptosis in human leukemia K562 cells via activation of mitochondrial pathway.
Topics: Apoptosis; Caspase 3; Cell Shape; Chalcone; Humans; K562 Cells; Leukemia; Membrane Potential, Mitochondrial; Mitochondria; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |
Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: The relationship between mitochondrial damage, oxidative stress, and cell death.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chalcone; Chalcones; Humans; Leukemia; Mitochondria; Oxidative Stress; Reactive Oxygen Species | 2010 |
Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells.
Topics: Angelica; Apoptosis; Caspase 3; Caspases; Chalcone; Enzyme Activation; Humans; Leukemia; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2005 |
Synthesis, dimerization, and biological activity of hexaoxygenated chalcones related to calythropsin and combretastatins.
Topics: Animals; Brain; Chalcone; Drug Screening Assays, Antitumor; Inhibitory Concentration 50; Leukemia; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Photochemistry; Spectrophotometry, Infrared; Structure-Activity Relationship; Swine; Tubulin; Tumor Cells, Cultured | 2002 |
New-type inducers of differentiation of HL-60 leukemia cells suppress c-myc expression.
Topics: Cell Differentiation; Cell Line; Chalcone; Chalcones; Humans; Leukemia; Oncogenes; Propiophenones; Proto-Oncogenes | 1987 |